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Alzheimer's disease (AD) is a progressive, neurodegenerative brain disorder characterized by
extracellular accumulations of amyloid β (Aβ) peptides, intracellular accumulation of abnormal
proteins, and early loss of basal forebrain neurons. Recent studies have indicated that the
conformation of Aβ is crucial for neuronal toxicity, with intermediate misfolded forms such as
oligomers being more toxic than the final fibrillar forms. Our previous work shows that Aβ blocks
the potassium (K+) currents IM and IA in septal neurons, increasing firing rates, diminishing
rhythmicity and firing coherence. Evidence also suggests that oxidative stress (OS) plays a role in
AD pathogenesis. Thus we wished to determine the effect of oligomeric and fibrillar forms of
Aβ1–42 on septohippocampal damage, oxidative damage, and dysfunction in AD. Oligomeric and
fibrillar forms of Aβ1–42 were injected into the CA1 region of the hippocampus in live rats. The
rats were sacrificed 24 hours and 1 month after Aβ or sham injection to additionally evaluate the
temporal effects. The expression levels of the K+ voltage-gated channel, KQT-like subfamily,
member 2 (KCNQ2) and the OS-related genes superoxide dismutase 1, 8-oxoguanine DNA
glycosylase, and monamine oxidase A, were analyzed in the hippocampus, medial, and lateral
septum. Our results show that both forms of Aβ exhibit time-dependent differential modulation of
OS and K+ channel genes in the analyzed regions. Importantly, we demonstrate that Aβ injected
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into the hippocampus triggered changes in gene expression in anatomical regions distant from the
injection site. Thus the Aβ effect was transmitted to anatomically separate sites, because of the
functional coupling of the brain structures.
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1. Introduction

Author Manuscript

Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that causes memory
loss, dementia, and death. The more common sporadic form of AD is correlated with aging,
and the increase of life expectancy is transforming AD into a major health problem in the
developed and developing world. Although the mechanisms that lead to brain dysfunction
and neurodegeneration in AD are not clearly understood, extracellular accumulation of
amyloid beta peptides (Aβ) is a defining feature of this pathology, leading to the idea that
amyloid accumulation plays an important role in the development of the disease.
One of the main pathological features of AD is the pathological misfolding of Aβ to adopt a
β-sheet conformation (Di Carlo et al., 2012). This occurs via a nucleated polymerization
mechanism; this involves the formation of soluble, oligomeric intermediate pathogenic
species, and terminating with the formation of fibrillar Aβ, which are now thought to be
nonpathogenic (Fändrich, 2012).

Author Manuscript
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Oxidative damage is observed in the brain of AD patients (Butterfield et al., 2001) and
oxidative stress (OS) leads to an increased Aβ production that, in turn, exacerbates OS (Irie
et al., 2007; Murray et al., 2007; Tong et al., 2005). Thus, OS and increased Aβ might create
a deleterious cycle that concludes with membrane damage, cytoskeleton alterations, and cell
death (Perry et al., 2000). Some of the proposed mechanisms behind AD and OS include the
Aβ interaction with redox active metal ions, which are a significant source of OS, inducing
neurotoxicity via cell-free hydrogen peroxide generation (Huang et al., 1999) in a protective
pathway that includes the activity of the enzyme superoxide dismutase (SOD1) as an
intermediate step (Marlatt et al., 2004). Another major modification is the oxidative damage
of DNA. Mutations in mitochondrial DNA cause a respiratory chain dysfunction, which can
increase cellular OS. It is established that mitochondrial mutations accumulate during brain
aging and neurodegenerative diseases (Santos et al., 2010). Although several oxidized bases
can result from attack on DNA by OS, the predominant marker is 8-hydroxy-2′deoxyguanosine (8-OHdG), that induces a G:C → A:T transversion (Shibutani et al., 1991),
reverted mainly by the antioxidant enzyme 8-oxoguanine DNA glycosylase (OGG1) (Tchou
et al., 1991). New evidence suggests impaired function of enzymes related to recycling
neurotransmitters like monoamine oxidase (MAO) are indirect generators of cytotoxic freeradicals during aging and in neurodegenerative diseases (Richards et al., 1998). Because of
the relevant role of these enzymes in oxidative damage and protection from this type of
insult, we postulate that the presence of increased concentrations of Aβ forms could lead to a
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modified response in their gene expression and that this change might contribute to the
progression of this disorder within the brain.

Author Manuscript

Our previous studies have shown that administration of fibrillar Aβ into the hippocampus
leads to the formation of localized Thioflavin S-positive amyloid β lesions in the
hippocampus and a reduction of medial septum neuronal numbers, suggesting a complex
damage response network (Colom et al., 2011). Furthermore, Aβ excess produces brain
dysfunction and degeneration via modification of potassium (K+) currents (e.g., IM, IA, and
IK) (Colom et al., 1998; Leão et al., 2012), that will result in: (1) loss of rhythmic states that
promote synaptic plasticity and memory formation (Colom et al., 2010; Leão et al., 2012);
(2) hyperexcitability, including epilepsy, as found in AD patients and animal models
(Noebels, 2011); and (3) cell death mechanisms (Colom et al., 1998). The neurotransmittermodulated IM current is carried in the brain mainly by the KCNQ2/3 subunits and is
particularly affected by oligomeric Aβ in glutamatergic septal neurons (Leão et al., 2012)
and, thus, might play a role in the memory loss observed in AD patients.
In the present study, we analyze the expression of the OS-related genes SOD1, OGG1, and
MAOA, and the K+ channel subunit KCNQ2 (Kv7.2) in the hippocampus, medial, and lateral
septum after hippocampal CA1 exposure to oligomeric and fibrillar forms of Aβ.

2. Methods
2.1. Animals

Author Manuscript

A total of 24 adult Sprague Dawley rats (9 weeks old, and weight 250–300 g; Harlan) were
housed and maintained on a 12-hour light/dark cycle and provided food and water ad
libitum. All animal protocols used in this study were in compliance with the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee of the University of Texas Brownsville and
Texas Southmost College (UTB/TSC). All surgical procedures were performed with a
ketamine-based anesthetic (ketamine: 43.2 mg/mL, xylazine: 8.6 mg/mL, and acepromazine:
1.35 mg/mL in saline; 1 mL/kg). Groups of rats were sacrificed for gene analaysis at 24
hours and 1 month after Aβ injection or sham treatment.
2.2. Aβ preparation

Author Manuscript

2.2.1. Oligomers—Aβ1–42 and Aβ42–1(.5 mg each) (California Peptide) were dissolved in
22 μL of anhydrous dimethyl sulfoxide (DMSO) to yield a 5 mM solution, then diluted to a
concentration of 100 μM by adding 490 μL of phosphate buffered saline (PBS) pH 7.4 and
10 μL of DMSO solution. Amyloid β oligomers were then generated by incubation for 17
hours at 4 °C (De Felice et al., 2008).
2.2.2. Fibrils—Aβ1–42 and Aβ42–1 (.5 mg each) (California Peptide) were dissolved in 22
μL of anhydrous dimethyl sulfoxide (DMSO) to yield a 5 mM solution, 10 μL was further
diluted to 100 μM solution by adding 490 μL of hydrochloric acid (HCL) (10 mM). Fibrillar
amyloid was formed by incubation for 87 hours at 37 °C (De Felice et al., 2008).
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2.3. Atomic force microscopy
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Atomic force microscopy (AFM) was used to confirm the oligomeric and fibrillary forms of
the Aβ preparations. A 1-μL portion from each Aβ solution (previous paragraph) was diluted
10 times using PBS 7.4 pH. Then approximately 50-μL drops from each solution were
incubated at room temperature for 30 minutes with 2 freshly-cleaved mica surfaces. The
samples were rinsed 5 times with deionized water to remove the nonadsorbed proteins.
Finally, the samples were air-dried for 30 minutes and imaged in air. AFM measurements
were performed in contact mode at room temperature using a Multimode AFM with a
Nanoscope IV Controller (Digital Instruments, Veeco, Santa Barbara, CA, USA) and Vshaped Si3N4 cantilevers with oxide-sharpened tips (Olympus; spring constant of 0.15 N/m).
As can be seen in Fig. 1A, the oligomeric Aβ peptide homogeneously covers the mica
surface and appears as single beads or small aggregates. The AFM cross-section (Fig. 1C)
shows that the size of these single beads is approximately 4 nm which is similar to the
average size of a single Aβ protein. The fibrillar Aβ peptide is a mixture of short fibrils (with
various lengths) and a single protein (Fig. 1B). As shown in Fig. 1D the width of the fibrils
is approximately 8 nm which is twice the size of a single Aβ peptide.
2.4. Aβ injections

Author Manuscript

Rats were anesthetized using a combination of anesthetics (0.3 mL/kg, containing ketamine
[42.8 mg/mL], xylazine [8.6 mg/mL], and acepromazine [1.4 mg/mL]), and unilateral
microinjections of Aβ1–42 (oligomeric and fibrillar forms as separated groups) (10 μg in 5
μL of sterile PBS) were administered into the CA1 region of the hippocampus using
stereotaxic coordinates derived from the Paxinos and Watson atlas (3.4–3.6 mm posterior
from bregma, 2 mm lateral, and 2.3–2.5 mm vertical) (Paxinos and Watson, 1998). All
microinjections were administered using a 10-μL Hamilton syringe which was slowly
lowered into the CA1 hippocampal region. The needle was left in place for approximately 10
minutes before the injection of peptide. Thereafter, Aβ1-42 was injected at a rate of 1 μL per
minute. The needle was left in place for an additional 10 minutes after the injection of Aβ to
prevent transport of the peptide up the needle tract. Control rats received a unilateral
hippocampus micro-injection of identical volume of the reverse oligomeric and fibrillar
peptides Aβ42–1, following the same protocol.
2.5. Medial septum/diagonal band, lateral septum, and hippocampal extraction of tissue

Author Manuscript

To evaluate the influence of Aβ conformation and time of exposure to the peptides on gene
expression, we analyzed the previously described specific genes. The injected animals were
divided in 2 groups, 24 hours and 1 month after Aβ injection. The first group (24 hours) was
evaluated for short-term effects of Aβ and the second group (1 month) was evaluated for
chronic exposure to Aβ and sacrificed 30 days after the injection.
Rats were deeply anesthetized using a combination of anesthetics (0.7 mL/kg, containing
ketamine [42.8 mg/mL], xylazine [8.6 mg/mL], and acepromazine [1.4 mg/mL]) and rapidly
decapitated. The brain was then removed and immersed in ice-cold, diethylpyrocarbonate
(DEPC)-treated PBS aerated with 95% O2 and 5% CO2 to equilibrate the pH at 7.3–7.4. The
brain was mounted on a plastic tray with cyanoacrylate glue. Coronal slices (300 μm thick)
containing the medial septum/diagonal band (MS) were prepared using a vibratome
Neurobiol Aging. Author manuscript; available in PMC 2016 June 02.
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(OTS-4000; EMS, Hatfield, PA, USA). The MS and lateral septum (LS) structures of the
basal forebrain were carefully dissected using 25-gauge needles. MS and LS slices were
transferred into RNAlater solution (Applied Biosystems) for later processing.
After slicing the medial septum, the remaining brain tissue was unglued from the tray and
placed into a petri dish (filled with DEPC-treated PBS and aerated with 95% O2 and 5%
CO2). The hippocampus was removed parasagittally and immediately transferred into a
microtube filled with PBS-DEPC RNAlater solution.
2.6. RNA isolation, cDNA library, and real-time quantitative polymerase chain reaction
analysis

Author Manuscript
Author Manuscript
Author Manuscript

Total RNA was isolated from the dissected hippocampus, lateral, and medial septum. In
brief, tissue was collected, weighed, homogenized, and processed for total RNA isolation at
4 °C using RNAqueous-4PCR Kit (Applied Biosystems) following the manufacturer's
instructions. The concentration and purity of total RNA for each sample was determined
with a Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, DE, USA)
by calculating the ratio of optical density at wavelengths of 260 nm and 280 nm. Trace
amount of genomic DNA contamination were minimized by digesting genomic DNA using
DNA-free DNase Treatment (Applied Biosystems) following the manufacturer's protocols.
Reverse transcription (RT) was performed with an iCycler Thermal Cycler polymerase chain
reaction (PCR) System (Bio-Rad Laboratories, Hercules, CA, USA), using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) for synthesis of a singlestranded cDNA library. The cDNA synthesis was carried out according to the manufacturer's
protocol using random primers for 1 μg of starting RNA. Each RT reaction contained 1 μg of
extracted total RNA template and RT reagents. The 20-μL reactions were incubated for 10
minutes at 25 °C, 120 minutes at 37 °C, 5 seconds at 85 °C, and then held at 4 °C. The
resulting cDNA template was subjected to real-time quantitative PCR using Taqman-based
ABI gene expression assays, TaqMan Fast Universal PCR Master Mix (ABI), and the
StepOne real-time thermocycler engine (ABI). Gene expression analysis was performed
using the following assays: Rn00566938_m1 for target gene SOD1 (RefSeq:
NM_017050.1), Rn00578409_m1 for target gene OGG1 (RefSeq: NM_030870.1),
Rn00591249_m1 for target gene KCNQ2 (Ref Seq NM_133322.1), Rn01430950_m1 for
target gene MAOA (RefSeq: NM_033653.1), and the bioassay Rn99999916_s1 for the
normalization gene glyceral-dehyde-3-phosphate dehydrogenase (GAPDH; RefSeq:
NM_017008.3). Each sample was run in triplicate and a nontemplate control to test for
contamination of assay reagents was also included in the plate. After a 94 °C denaturation
for 10 minutes, the reactions were cycled 40 times with a 94 °C denaturation for 15 seconds,
and 60 °C annealing for 1 minute. Three types of controls aimed at detecting genomic DNA
contamination in the RNA sample or during the RT or quantitative PCR reactions were
always included: an RT mixture without reverse transcriptase, an RT mixture including the
enzyme but no RNA, and a negative control (reaction mixture without cDNA template). The
data were collected and analyzed using OneStep Software version 2.2.2 (ABI). Relative
quantification was performed using the comparative threshold (CT) method after
determining the CT values for reference (GAPDH) and target (SOD1, OGG1, KCNQ2, and
MAOA) genes in each sample set according to the ΔΔCT method (Pfaffl, 2006) as described
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by the manufacturer (Applied Biosystems; User Bulletin 2). Changes in messenger RNA
(mRNA) expression level were calculated after normalization to GAPDH. As a calibrator
sample, we used cDNA from an arbitrarily selected control rat. Values of fold changes in the
control sample versus the Aβ-injected samples represent averages from triplicate
measurements. Changes in gene expression were reported as percent changes relative to
controls. Data were analyzed by 1-way analysis of variance with a significance p value set at
<0.05.

3. Results
3.1. MS

Author Manuscript

Overall, in the 24-hour group, the analyzed OS genes were downregulated in the medial
septum after injection of oligomeric and fibrillar Aβ. The largest change occurred in OGG1
expression (−0.50 ± 0.09; p < 0.001) in the rats injected with the oligomeric form of Aβ
(Fig. 2D). Though the expression of the KCNQ2 gene was reduced in the group injected
with oligomeric Aβ (−0.22 ± 0.06; p < 0.05), this gene was significantly overexpressed (0.58
± 0.04; p < 0.001) in the group injected with the fibrillar form (Fig. 2A).
The chronic effects (after 1 month) of oligomeric Aβ differed from that of rats exposed to
oligomeric Aβ for 24 hours. The downregulation of the OGG1 (−0.60 ± 0.13; p < 0.001) and
KCNQ2 (−0.27 ± 0.01; p < 0.001) genes were maintained, but the level of SOD1 (0.66
± 0.16; p < 0.001) was significantly increased, and MAOA (not significant) showed a lesser
increase (Fig. 2D).
3.2. LS

Author Manuscript

Gene expressions in the lateral septum for the 24-hours injected group was more diverse
than the medial septum with opposite effects being observed for the 2 forms of Aβ. Though
the same genes were downregulated as in the medial septum, the MAOA gene was more
vulnerable and exhibited greater downregulation (−0.58 ± 0.11; p < 0.001) than fibrillar Aβ
(Fig. 2B).
In contrast to the effects of the fibrillar form, the oligomeric Aβ resulted in increased
expression of all the studied genes in the lateral septum, with KCNQ2 (0.66 ± 0.3; p = 0.03)
showing the higher values (Fig. 2E). Though not significant, both forms of Aβ resulted in an
upregulation of the SOD1 gene maintained in the lateral septum.

Author Manuscript

After 30 days after Aβ injection, the response was reversed for both forms of Aβ. There was
an overall downregulation among all investigated genes in animals injected with the
oligomeric form: SOD1 (−0.75 ± 0.08; p < 0.001), OGG1 (−0.38 ± 0.01; p = 0.01), MAOA
(−0.27 ± 0.01; p < 0.001), and KCNQ2 (−0.45 ± 0.04; p = 0.001) (Fig. 2E); and with fibrillar
Aβ there was overexpression in the analyzed genes SOD1 (0.79 ± 0.2; p = 0.003), OGG1
(0.39 ± 0.07; p < 0.001), MAOA (0.12 ± 0.01; p = not significant), and KCNQ2 (0.76 ± 0.04;
p < 0.001) (Fig. 2B).
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3.3. Hippocampus
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After 24 hours after intrahippocampal injection with fibrillar Aβ, all the analyzed genes were
overexpressed (Fig. 2C). However, the effect of injection of oligomeric Aβ in the
hippocampus was totally opposite: KCNQ2 showed a significant reduction in expression
(−0.59 ± 0.01; p < 0.001). The most remarkable results were in the chronic group (1 month)
because both Aβ forms showed the same expression profile for all analyzed genes (Fig. 2C
and F).

4. Discussion

Author Manuscript

We selected the rat as a model to investigate the time-dependent effect of Aβ conformation
(oligomeric of fibrillar) on a group of genes relevant in AD pathophysiology: specifically,
the KCNQ2 ion channel and OS markers. We selected young adult rats for our
experimentation based on the following rationale. Though AD is an aging-related brain
disorder, Aβ deposition and functional alterations start many years before AD diagnosis
(Holtzman, 2008; Verghese et al., 2011). Even more, in commercially recognized rat models,
Alzheimer pathology can be induced in young rats (Lecanu et al., 2006). Thus, it is
important to investigate Aβ effects in young, adult, and aged animals to determine the
molecular changes that might trigger the initiation of AD dysfunction and pathology.

Author Manuscript

We demonstrate that intrahippocampal administration of Aβ modified the gene expression in
several brain areas: hippocampus and medial and lateral septum. Because the
septohippocampal system plays a central role in memory processes affected in AD and the
septal region has been implicated in mood disorders frequently observed in AD (Colom et
al., 2006), the observed changes in these brain lesions might be particularly relevant to the
pathogenesis of this disorder.
Intrahippocampal administration of Aβ produced changes in 2 basal forebrain structures
with different neuronal populations and connectivity. We propose that the septal changes can
be explained by the following mechanisms: (1) Aβ could directly affect presynaptic
terminals of septohippocampal neurons, leading to alterations in other neuronal
compartments; (2) Aβ could alter the function and damage hippocampal neurons, leading to
gene expression alteration in the synaptically connected brain structures; or (3) a
combination of both mechanisms.

Author Manuscript

The medial septal brain region is composed of cholinergic, glutamatergic, and GABAergic
neurons, with neurons in each of these neuronal populations projecting to the hippocampus.
As feedback, the medial septum receives a small projection from hippocampal GABAergic
neurons (Colom et al., 2006). The lateral septum is mostly composed of GABAergic
neurons, and receives glutamatergic projection from the hippocampus, but does not project
to the hippocampus. Because the hippocampus does not receive input from lateral septal
axons, a retrograde feedback mechanism cannot explain the lateral septal alterations
produced by hippocampal perturbations, such as Aβ accumulation.
We propose the following “activity-dependent” model that is consistent with our previous
work and provides an explanation of our current results. Initially, administration of
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oligomeric Aβ blocks IM and IA K+ conduction in septal neurons (Leão et al., 2012). In the
hippocampus, the expression of the KCNQ2 is probably reduced by the Aβ-induced damage.
We propose that Aβ, through the K+ channel block, rapidly increases the firing rates of
hippocampal principal and GABAergic interneurons, impairing rhythmicity and synchronic
activities. As a result of this alteration, hippocampal outputs are also modified. The
hippocampal–medial septal output is GABAergic, and thus, an increase in its activity will
lead to medial septal inhibition with consequent reduction of OS gene expression as
observed in the acute oligomeric Aβ-treated group. To compensate for the reduced neuronal
activity in the medial septum, the expression of the KCNQ2 gene is lowered. In contrast, the
hippocampal–lateral septal output is glutamatergic and its activation will intensify lateral
septal network activity with consequent increases of OS gene expression. Thus in the lateral
septum, the expression of the KCNQ2 gene is augmented to compensate for the
intensification of neuronal activity.

Author Manuscript

During the following weeks, with chronic oligomeric Aβ treatment, this reduced expression
of KCNQ2 was maintained and extended to the lateral septum, probably indicating a failed
compensatory response to restore to the natural and pre-Aβ injection status. These results
illustrate that Aβ can lead to a reduced expression of the KCNQ2 gene in functionally related
structures and prove that K+ channel genes are susceptible to oligomeric Aβ influence.
Finally, fibrillary Aβ is less effective in modulating K+ channels (Leão et al., 2012) and its
neurotoxicity is probably related to alternative mechanisms (e.g., delayed IK enhancement;
Colom et al., 1998), producing different patterns of OS and K+ channel gene expression.

Author Manuscript

Our work also demonstrates changes in OS markers. We show that: (1) the analyzed OSrelated genes modify their expression profile under the influence of Aβ; (2) those changes
appear in a short period of time; and (3) changes in function and neuronal damage might
involve multiple OS pathways and that OS changes might be related to functional changes.
Our “activity-dependent” model predicts early changes after oligomeric Aβ accumulation.
Later changes need to incorporate compensatory mechanisms that are not yet fully
understood.

Author Manuscript

For example, the expression of the antioxidant gene (SOD1) is affected by the
administration of oligomeric Aβ. An early decreased expression followed by a significant
overexpression was observed in the medial septum and the hippocampus. Late increases
were not observed in the lateral septum. Because SOD1 has antioxidant roles, lower levels of
SOD1 in the lateral septum might increase its vulnerability to gradual accumulation of
reactive oxygen species, contributing to Aβ-induced damage. These results can be correlated
with the work of Kent and collaborators (Kent et al., 1999) who demonstrated that lower
expression of the SOD1 gene is a common feature in the brain of aging rodents, but a
compensatory over-expression could also result in an increased toxicity because of the
excessive conversion of superoxide to O2 and H2O2 (the main function of SOD1). Thus, the
alterations in the expression of this gene play an important role in the early stages and
progression of AD.
Also, OS induction of modifications on DNA sequences might critically contribute to the
brain damage. Any maintained DNA damage becomes irreparable (Freitas and de
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Magalhães, 2011) To avoid this negative outcome, DNA oxidation is repaired by OGG1 in
nuclear and mitochondrial fractions (Wang et al., 2011). With aging, the levels of OGG1

Author Manuscript

decrease in the mitochondria of different tissues, suggesting a reduced repair capability
(Stevnsner et al., 2002). Our work shows that oligomeric Aβ significantly decreases the
expression profile of the DNA repair gene OGG1 and suggests that lessened repair
mechanisms might contribute to the Aβ-induced damage. Although the present study did not
investigate the occurrence of new mutations in nuclear or mitochondrial fractions, our results
suggest that any change in DNA by the most common mutagenic element, 8-OHdG, can
lead to permanent DNA modifications because of the lower expression levels of the OGG
gene. These lower expression levels might produce an impaired damage response with
devastating consequences in AD, particularly in mitochondrial RNA (Lin et al., 2011; Wang
et al., 2011). The lack of DNA repair capability might contribute to neurodegeneration and
cell dysfunction. Because it has been reported that OGG activity shows an inverse
correlation with levels of 8-OHdG in mild cognitive impairment and AD, DNA changes
might play an important role in the development of the disorder before the full expression of
AD symptomatology (Shao et al., 2008).
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It has been proposed that neurodegeneration with subsequent reduction of neuronal
populations can trigger diverse compensatory responses from the remaining neurons in the
brain, including an increased expression of the mRNA levels of the MAOA gene, as
observed in postmortem neurons of AD patients (Emilsson et al., 2002). Because MAO is an
indirect generator of cytotoxic free-radicals, this overexpression can lead to more OS, as
observed in aging and AD (Hermida-Ameijeiras et al., 2004; Richards et al., 1998). In the
present work, the MAOA gene expression was most robustly reduced in the lateral septum
after chronic exposure (1 month) to Aβ. A decreased expression of MAOA in the
hippocampus under the influence of both Aβ forms was also observed, suggesting that
increased expression profiles might not be a part of early stages of AD.
Independent of the mechanisms underlying the proposed changes, we provide evidence that
limited deposition of Aβ resulted in modified gene expression in several functionally-related
brain structures. We demonstrated that gene expression changes do not require Aβ contact
with dendrosomatic neuronal compartments and that the presence of: (1) presynaptic
terminals in close proximity with Aβ deposits; or (2) simply Aβ-triggered functional
changes, might be sufficient to alter gene expression in functionally related brain structures.
Thus, Aβ accumulation might lead to neuronal dysfunction and damage that could not be
fixed because of the reduced of expression of repairing genes.

Author Manuscript
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Fig. 1.

(A) Deflection atomic force microscopy (AFM) image of the oligomeric amyloid beta (Aβ)
showing single and aggregate proteins. (B) Deflection AFM image of the fibrillar Aβ
indicating the coexistence of fibrils and single proteins (fibrils have various lengths). (C)
AFM cross-section along the line shown in (A) (black line). The Aβ oligomers are
approximately 4 nm in size. (D) AFM cross-section along the line shown in (B). The width
of the single Aβ fibrils is approximately 8 nm.
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Fig. 2.

Relative expression of SOD, OGG, MAOA, and KCNQ2 genes with altered messenger RNA
(mRNA) levels in the (A, B, and C) fibrillar and (D, E, and F) oligomeric analyzed groups.
Expression levels of the genes were analyzed by quantitative reverse transcription
polymerase chain reaction and normalized over GAPDH. *p < 0.05, **p < 0.001 (when
compared with respective reverse peptide controls). Error bars indicate standard error.
Abbreviations: Aβ, amyloid beta; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
KCNQ2, potassium voltage-gated channel, KQT-like subfamily, member 2; MAOA,
monoamine oxidase A; SOD, superoxide dismutase.
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